Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability – considerations for drug development
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability – considerations for drug development
Authors
Keywords
-
Journal
Expert Opinion on Drug Metabolism & Toxicology
Volume 8, Issue 6, Pages 723-743
Publisher
Informa Healthcare
Online
2012-04-18
DOI
10.1517/17425255.2012.678048
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BDDCS Applied to Over 900 Drugs
- (2011) Leslie Z. Benet et al. AAPS Journal
- A Common 5′-UTR Variant in MATE2-K Is Associated With Poor Response to Metformin
- (2011) J H Choi et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Targeting Intestinal Transporters for Optimizing Oral Drug Absorption
- (2011) Manthena V. Varma et al. CURRENT DRUG METABOLISM
- Pharmacogenetics of OATP Transporters Reveals That SLCO1B1 c.388A>G Variant Is Determinant of Increased Atorvastatin Response
- (2011) Alice C. Rodrigues et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cerivastatin, genetic variants, and the risk of rhabdomyolysis
- (2011) Kristin D. Marciante et al. Pharmacogenetics and Genomics
- The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c
- (2011) Mette M.H. Christensen et al. Pharmacogenetics and Genomics
- Pharmacogenetics of drug transporters in the enterohepatic circulation
- (2011) Bruno Stieger et al. PHARMACOGENOMICS
- Pharmacogenetic analyses of cisplatin-induced nephrotoxicity indicate a renoprotective effect ofERCC1polymorphisms
- (2011) Mladen V Tzvetkov et al. PHARMACOGENOMICS
- Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake
- (2011) M. Niemi et al. PHARMACOLOGICAL REVIEWS
- Discovery of novel hepatoselective HMG-CoA reductase inhibitors for treating hypercholesterolemia: A bench-to-bedside case study on tissue selective drug distribution
- (2010) Jeffrey A. Pfefferkorn et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Response: Why It Is Time to Sequence
- (2010) Jon McClellan et al. CELL
- P-glycoprotein related drug interactions: clinical importance and a consideration of disease states
- (2010) Caroline A Lee et al. Expert Opinion on Drug Metabolism & Toxicology
- Genetic Polymorphisms in Organic Cation Transporter 1 (OCT1) in Chinese and Japanese Populations Exhibit Altered Function
- (2010) L. Chen et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Improved Extrapolation of Hepatobiliary Clearance fromin VitroSandwich Cultured Rat Hepatocytes through Absolute Quantification of Hepatobiliary Transporters
- (2010) Na Li et al. MOLECULAR PHARMACEUTICS
- Membrane transporters in drug development
- (2010) NATURE REVIEWS DRUG DISCOVERY
- Influence of ABCB1 genetic polymorphisms on the pharmacokinetics of levosulpiride in healthy subjects
- (2010) H.Y. Cho et al. NEUROSCIENCE
- OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine
- (2010) Zhi-Jun Wang et al. Pharmacogenetics and Genomics
- Heterozygous variants of multidrug and toxin extrusions (MATE1 and MATE2-K) have little influence on the disposition of metformin in diabetic patients
- (2010) Kana Toyama et al. Pharmacogenetics and Genomics
- Effects of OCT1 polymorphisms on the cellular uptake, plasma concentrations and efficacy of the 5-HT3 antagonists tropisetron and ondansetron
- (2010) M V Tzvetkov et al. PHARMACOGENOMICS JOURNAL
- No significant effect ofABCB1haplotypes on the pharmacokinetics of fluvastatin, pravastatin, lovastatin, and rosuvastatin
- (2009) Jenni E. Keskitalo et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Contribution of Organic Cation Transporter 2 (OCT2) to Cisplatin-Induced Nephrotoxicity
- (2009) K K Filipski et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Role of Organic Anion–Transporting Polypeptides and Their Common Genetic Variants in Mycophenolic Acid Pharmacokinetics
- (2009) N Picard et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Effects of Genetic Polymorphisms in the Organic Cation Transporters OCT1, OCT2, and OCT3 on the Renal Clearance of Metformin
- (2009) M V Tzvetkov et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin
- (2009) J E Keskitalo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Genetic Variation in the Multidrug and Toxin Extrusion 1 Transporter Protein Influences the Glucose-Lowering Effect of Metformin in Patients With Diabetes: A Preliminary Study
- (2009) M. L. Becker et al. DIABETES
- Functional Characterization of the Human Organic Cation Transporter 2 Variant p.270Ala>Ser
- (2009) O. Zolk et al. DRUG METABOLISM AND DISPOSITION
- In vitro-in vivo Extrapolation of Transporter-mediated Clearance in the Liver and Kidney
- (2009) Hiroyuki Kusuhara et al. Drug Metabolism and Pharmacokinetics
- Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs
- (2009) Ichiro Ieiri et al. Expert Opinion on Drug Metabolism & Toxicology
- Oral Sulfasalazine as a Clinical BCRP Probe Substrate: Pharmacokinetic Effects of Genetic Variation (C421A) and Pantoprazole Coadministration
- (2009) Kimberly K. Adkison et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin
- (2009) Ying Chen et al. Pharmacogenetics and Genomics
- Interaction between polymorphisms in the OCT1 and MATE1 transporter and metformin response
- (2009) Matthijs L. Becker et al. Pharmacogenetics and Genomics
- Polymorphic variants in the human bile salt export pump (BSEP; ABCB11): functional characterization and interindividual variability
- (2009) Richard H. Ho et al. Pharmacogenetics and Genomics
- Different effects of theABCG2c.421C>A SNP on the pharmacokinetics of fluvastatin, pravastatin and simvastatin
- (2009) Jenni E Keskitalo et al. PHARMACOGENOMICS
- Meta-Analysis of the Effect of MDR1 C3435T Polymorphism on Cyclosporine Pharmacokinetics
- (2008) Zhi-Ping Jiang et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Physiochemical drug properties associated with in vivo toxicological outcomes
- (2008) Jason D. Hughes et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The effect ofSLCO1B1polymorphism on repaglinide pharmacokinetics persists over a wide dose range
- (2008) Annikka Kalliokoski et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- ABCB1 Haplotypes Differentially Affect the Pharmacokinetics of the Acid and Lactone Forms of Simvastatin and Atorvastatin
- (2008) JE Keskitalo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenetic Characterization of Sulfasalazine Disposition Based on NAT2 and ABCG2 (BCRP) Gene Polymorphisms in Humans
- (2008) Y Yamasaki et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Genetic Variants of the Organic Cation Transporter 2 Influence the Disposition of Metformin
- (2008) IS Song et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A Ligand-Based Approach to Mining the Chemogenomic Space of Drugs
- (2008) Elisabet Gregori-Puigjane et al. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
- Organic Cation Transporters and their Pharmacokinetic and Pharmacodynamic Consequences
- (2008) Min-Koo Choi et al. Drug Metabolism and Pharmacokinetics
- Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment
- (2008) Jürgen Brockmöller et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Physiologically Based Pharmacokinetic Modeling to Predict Transporter-Mediated Clearance and Distribution of Pravastatin in Humans
- (2008) T. Watanabe et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe
- (2008) Bradley L. Urquhart et al. Pharmacogenetics and Genomics
- Polymorphism in human organic cation transporters and metformin action
- (2008) Hiroshi Takane et al. PHARMACOGENOMICS
- Postmenopausal Hormone Therapy for Disease Prevention: Have We Learned Any Lessons from the Past?
- (2007) J E Rossouw CLINICAL PHARMACOLOGY & THERAPEUTICS
- Global analysis of genetic variation in SLCO1B1
- (2007) Marja K Pasanen et al. PHARMACOGENOMICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now